XBiotech Inc (XBIT NASDAQ) stock market data APIs
$3.0582
0(0%)
as of July 8, 2025
Try our APIs with
free plan!
XBiotech Inc Financial Data Overview
Price chart is built with
Anychart
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Prev. Close
3.0582
Open
3.0582
High
3.1256
Low
2.9806
52 wk Range
2.5-8.32
Market Cap
92 378 K
Shares Outstanding
30 488 K
Revenue
300 K
EPS
-0.357
Beta
0.966
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get XBiotech Inc data using free add-ons & libraries
Get XBiotech Inc Fundamental Data
XBiotech Inc Fundamental data includes:
- Net Revenue: 300 K
- EBITDA: -43 413 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-08
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
XBiotech Inc News
New
3 Promising Penny Stocks With Market Caps Above $90M
As the U.S. stock market navigates a landscape shaped by trade talks and economic data, investors are keenly watching for opportunities amid the shifting dynamics. Penny stocks, a term rooted in past ...
XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
XBiotech Inc. XBiotech Architectural Rendition of XBiotech’s Planned R&D Facility XBiotech Architectural Rendition of XBiotech’s Planned R&D Facility AUSTIN, Texas, Jan. 04, 2024 (GLOBE NEWSWIR...
Companies Like XBiotech (NASDAQ:XBIT) Are In A Position To Invest In Growth
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining exploration companies often lose money for years before finding success with a new trea...
Le Dr Alan Kivitz prend la tête du programme Natrunix, conduit par XBiotech dans le traitement de la polyarthrite rhumatoïde
AUSTIN, État du Texas, 15 nov. 2023 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : XBIT) annonce ce jour la nomination d’Alan Kivitz, M.D. au titre d’Investigateur principal et Président de la commis...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
